Home / Stocks / TAK

TAK insider trading

TAKEDA PHARMACEUTICAL CO LTD — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-09-03Plump Andrew Stewart
President, R&D
Sold116,191$18.49$2.1M
2026-08-12Kim Julie So-Young
President and CEO
Sold89,090$17.10$1.5M
2026-08-12Plump Andrew Stewart
President, R&D
Sold165,393$17.10$2.8M

See TAK on the chart

Every insider buy and sell for TAK plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.